By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

NanoString Technologies Inc. 

201 Elliott Avenue West
Suite 300
Seattle  Washington  98119  U.S.A.
Phone: 206-378-NANO Fax: 206-378-6288


SEARCH JOBS


Industry
Diagnostics






Company News
NanoString Technologies Inc. (NSTG) Highlights Important Results From Prosigna Decision Impact Study Presented At The 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium 12/16/2014 11:12:07 AM
NanoString Technologies Inc. (NSTG) Updates Prosigna FDA Labeling To Provide Greater Insight Into Probability Of Breast Cancer Recurrence Between Year 5 And 10 After Diagnosis 12/9/2014 2:23:04 PM
NanoString Technologies Inc. (NSTG) Announces Prosigna Presentations At The 2014 CTRC-AACR San Antonio Breast Cancer Symposium 12/2/2014 3:03:26 PM
NanoString Technologies Inc. (NSTG) To Present At Canaccord Genuity Medical Technology And Diagnostics Forum 11/7/2014 12:18:51 PM
NanoString Technologies Inc. (NSTG) Releases Financial Results For Third Quarter Of 2014 11/5/2014 7:26:15 AM
NanoString Technologies Inc. (NSTG) Announces Publication In The Journal Of Clinical Oncology Showing The Prosigna Assay Identifies Women With A Low Risk Of Late Distant Recurrence Of Breast Cancer 10/22/2014 10:46:03 AM
NanoString Technologies Inc. (NSTG) To Release Third Quarter 2014 Financial Results And Host Conference Call On Tuesday, November 4, 2014 10/10/2014 7:16:29 AM
NanoString Technologies Inc. (NSTG) Collaborates With Brigham and Women's Hospital In Boston To Accelerate Translation Of Genomic Discoveries Into Clinical Diagnostics In Oncology 10/7/2014 10:25:01 AM
NanoString Technologies Inc. (NSTG) Introduces Novel Gene Expression Panel For Immuno-Oncology Research 9/10/2014 11:36:58 AM
NanoString Technologies Inc. (NSTG) Announces Unexpected Death Of Chief Medical Officer, J. Wayne Cowens, MD 8/27/2014 8:30:44 AM
12345678910
//-->